Cargando…
Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to TRAIL-Induced Apoptosis
Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) induces apoptosis in a variety of cancer cell lines with little or no effect on normal cells. However, its effect is limited as some cancers including pancreatic cancer show de novo resistance to TRAIL induced apoptosis. In this study w...
Autores principales: | Mamaghani, Shadi, Simpson, Craig D., Cao, Pinjiang M., Cheung, May, Chow, Sue, Bandarchi, Bizhan, Schimmer, Aaron D., Hedley, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400624/ https://www.ncbi.nlm.nih.gov/pubmed/22829912 http://dx.doi.org/10.1371/journal.pone.0041102 |
Ejemplares similares
-
Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy
por: Mamaghani, Shadi, et al.
Publicado: (2009) -
Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells
por: Santha, Sreevidya, et al.
Publicado: (2016) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011) -
Interactomes of
Glycogen Synthase Kinase-3
Isoforms
por: Cormier, Kevin W., et al.
Publicado: (2023) -
Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β
por: Wu, Wei, et al.
Publicado: (2019)